Lobitaña, Ricaliza .

HRN: 22-91-19  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/05/2023
CEFUROXIME 1.5GM (VIAL)
05/06/2023
05/06/2023
IVT
1.5
Loading Dose Prior OR
Elective D&c
Waiting Final Action 
05/06/2023
CEFUROXIME 1.5GM (VIAL)
05/06/2023
05/07/2023
IVT
1.5g
Q8H X 3 Doses
S/P Cervical Punch Biopsy
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: